← Back
$ACRS All transactions

Aclaris Therapeutics, Inc.

A

$ Value

$0

Shares

961,700

Price

$0

Filed

Feb 6

Insider

Name

Walker Neal

Title

CEO

CIK

0001604457

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

961,700

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. | The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date. | Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.

Filing Info

Accession No.

0001604457-26-000007

Form Type

4

Issuer CIK

0001557746

Walker Neal's History

Date Ticker Type Value
2026-02-03 ACRS M
2026-02-03 ACRS F $65K
2026-02-03 ACRS M $0
2026-02-02 ACRS A $0
2026-02-02 ACRS A $0
2026-01-02 ACRS M
2026-01-02 ACRS F $29K
2026-01-02 ACRS M $0
2025-06-10 ALDX A $0
2025-06-10 ALDX A $0

Other Insiders at ACRS (90d)

Insider Bought Sold Last
Walker Neal
CEO
2026-02-03
Loerop James
Chief Business Officer
2026-02-03
Balthaser Kevin
Chief Financial Officer
2026-02-03
Davis Hugh M.
President and COO
2026-02-03
Hall Jesse Wayne
Chief Medical Officer
2026-02-02
Kolbeck Roland Wilhelm
Chief Scientific Officer
2026-02-02